tirzepatide phase 2 monotherapy in Chinese patients with early type diabetes: A randomized, double-blind, placebo-controlled 3 trial (SURPASS-CN-MONO) GLP-1 agonist clinical pipeline 2026:
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12

01200-X/asset/a888810c-3ccf-4f48-b252-0dfdf720d276/main.assets/gr3_lrg.jpg)




















